Organic compounds -- part of the class 532-570 series – Organic compounds – Four or more ring nitrogens in the bicyclo ring system
Reexamination Certificate
2006-10-03
2006-10-03
McKenzie, Thomas C. (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Four or more ring nitrogens in the bicyclo ring system
C544S255000, C544S256000, C544S258000, C544S277000, C544S278000, C544S279000, C544S280000, C544S284000, C514S249000, C514S260100, C514S261100, C514S262100, C514S263200, C514S265100, C514S266230, C514S264110
Reexamination Certificate
active
07115739
ABSTRACT:
This invention describes novel triazole compounds of formula IX:wherein Z1is nitrogen or CR9and Z2is nitrogen or CH, provided that at least one of Z1and Z2is nitrogen; G is Ring C or Ring D; Ring C is selected from a phenyl, pyridinyl, pyrimidinyl, pyridazinyl, pyrazinyl, or 1,2,4-triazinyl ring, wherein said Ring C has one or two ortho substituents independently selected from —R1; Ring D is a 5–7 membered monocyclic ring or 8–10 membered bicyclic ring selected from aryl, heteroaryl, heterocyclyl or carbocyclyl; Rxand Ryare independently selected from T-R3, or Rxand Ryare taken together with their intervening atoms to form a fused ring; R1, R3, and T are as described in the specification. The compounds are useful as protein kinase inhibitors, especially as inhibitors of GSK-3 and Aurora, for treating diseases such as diabetes, cancer, and Alzheimer's disease.
REFERENCES:
patent: 6184226 (2001-02-01), Chakravarty et al.
patent: 6589958 (2003-07-01), Frietze
patent: 2001/0018436 (2001-08-01), Cushing et al.
patent: 2003/0069248 (2003-04-01), Chakravarty et al.
patent: 2003/0187002 (2003-10-01), Mortlock et al.
patent: WO 98/02434 (1998-01-01), None
patent: WO 00/42029 (2000-07-01), None
Lee, S.J. et. al., “Discovery of Potent Cyclic GMP Phosphodiesterase Inhibitors . . . ” J. Med. Chem., 1995, vol. 38, No. 18, pp. 3547-3557.
Traxler, P., et al., “Use of Pharmacophore Model for the Design of EGF-R Tyrosine Kinase Inhibitors: 4-(Phenylamino)pyrazolo[3,4-d]pyrimidines”, J. Med. Chem., 40:3601-3616 (1997).
Ivashchenko, A.V., et al., “Synthesis and Study of Heteroaromatic Ligands Containing a Pyrimidine Ring,” Abstract, Khim. Geterotsikl. Soedin. 12:1673-1677 (1980).
Bebbington David
Binch Hayley
Charier Jean-Damien
Golec Julian M. C.
Knegtel Ronald
Che Jennifer G.
Dixon Lisa A.
McKenzie Thomas C.
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
LandOfFree
Triazole compounds useful as protein kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triazole compounds useful as protein kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazole compounds useful as protein kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3714483